MEGHAN SRI KARUTURI to Neoadjuvant Therapy
This is a "connection" page, showing publications MEGHAN SRI KARUTURI has written about Neoadjuvant Therapy.
Connection Strength
0.054
-
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2023 Jun; 199(3):457-469.
Score: 0.022
-
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer. Oncologist. 2019 06; 24(6):762-771.
Score: 0.017
-
Severe hyponatremia following cyclophosphamide infusion in breast cancer patients. Breast J. 2018 07; 24(4):691-692.
Score: 0.016